Evidence map›Paper›PMID 25710909›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.

Katarzyna Kaczmarek Michaels, Malini Natarajan, Zelda Euler, Galit Alter, Gregory Viglianti, Andrew J Henderson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Advances in HIV Research Using Mass Cytometry.Current HIV/AIDS reports · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A functional screen identifies transcriptional networks that regulate HIV-1 and HIV-2.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Article
  13. Targeting HIV-1 proviral transcription.Current opinion in virology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD4AIDS research and human retroviruses · 2018
    Review
  19. Barriers for HIV Cure: The Latent Reservoir.AIDS research and human retroviruses · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Katarzyna Kaczmarek MichaelsSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA 02118; Graduate Program in Molecular and Translational Medicine, Boston University School of Medicine, Boston, MA 02118;
Malini NatarajanStowers Institute for Medical Research, Kansas City, MO 64110;
Zelda EulerRagon Institute of MGH, MIT and Harvard University, Boston, MA 02139; and.
Galit AlterRagon Institute of MGH, MIT and Harvard University, Boston, MA 02139; and.
Gregory VigliantiDepartment of Microbiology, Boston University School of Medicine, Boston, MA 02118.
Andrew J HendersonSection of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA 02118; Graduate Program in Molecular and Translational Medicine, Boston University School of Medicine, Boston, MA 02118; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118 andrew.henderson@bmc.org.
Boston University · USRagon Institute of MGH, MIT and Harvard · USStowers Institute for Medical Research · US

Funding

Transcription mechanisms that contribute to HIV-1 latencyR01AI097117 · NIAID · BOSTON MEDICAL CENTER · PI HENDERSON, ANDREW J · 2013 to 2016
$1.7M
Oral Macrophage Function in the Context of Periodontal Disease and HIV InfectionR56DE023950 · NIDCR · BOSTON MEDICAL CENTER · PI GIBSON, FRANK C, HENDERSON, ANDREW J · 2013 to 2014
$1.1M
Transcriptional mechanisms that contribute to HIV-1 latencyR56AI097117 · NIAID · BOSTON MEDICAL CENTER · PI HENDERSON, ANDREW J · 2011 to 2011
$433k
NIAID NIH HHS AI097117NIAID NIH HHS R01 AI097117NIAID NIH HHS R56 AI097117NIDCR NIH HHS DE023950NIDCR NIH HHS R56 DE023950
6 · The paper itself

Abstract

CD4(+) T cell subsets differentially support HIV-1 replication. For example, quiescent CD4(+) memory T cells are susceptible to HIV-1 infection but do not support robust HIV-1 transcription and have been implicated as the primary reservoir of latent HIV-1. T cell transcription factors that regulate maturation potentially limit HIV-1 transcription and mediate the establishment and maintenance of HIV-1 latency. We report that B lymphocyte-induced maturation protein-1 (Blimp-1), a critical regulator of B and T cell differentiation, is highly expressed in memory CD4(+) T cells compared with naive CD4(+) T cells and represses basal and Tat-mediated HIV-1 transcription. Blimp-1 binds an IFN-stimulated response element within HIV-1 provirus, and it is displaced following T cell activation. Reduction of Blimp-1 in infected primary T cells including CD4(+) memory T cells increases RNA polymerase II processivity, histone acetylation, and baseline HIV-1 transcription. Therefore, the transcriptional repressor, Blimp-1, is an intrinsic factor that predisposes CD4(+) memory T cells to latent HIV-1 infection.

Indexed as

Gene Expression Regulation, ViralCD4-Positive T-LymphocytesCell LineGene ExpressionHIV-1HIV InfectionsHIV Long Terminal RepeatHumansImmunologic MemoryModels, BiologicalPositive Regulatory Domain I-Binding Factor 1Protein BindingProvirusesRepressor ProteinsT-Lymphocyte SubsetsTranscription, GeneticPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanRepressor Proteins

Identifiers

PMID25710909
PMCPMC4369419
OpenAlexW2126824012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.